4DMedical's participation in pivotal burn pit research grant

4DMedical Limited (ASX: $4DX) has secured participation in a pivotal burn pit research grant awarded by the U.S. Department of Veterans Affairs (VA). The grant will be utilized to advance the understanding of factors causing deployment related respiratory disease (DRRD) and improve non-invasive diagnosis of DRRD using 4DMedical's XV Technology®.

Executive commentary on pivotal burn pit research grant

4DMedical's MD/CEO and Founder, Andreas Fouras, expressed, '4DMedical's inclusion in this pivotal study cements our position as a leading technology for Veterans exposed to burn pits. 4DMedical's XV Technology will assist Veterans, clinicians and researchers at the VA to detect lung disease associated with toxic exposure sensitively and non-invasively. This project, combined with our recent news regarding the use of Imbio's LTA to detect pulmonary fibrosis in Veterans, highlights the growing profile and momentum 4D has at the VA, and I look forward to sharing further updates in the coming months.'

Summary of 4DMedical's participation in pivotal burn pit research grant

4DMedical Limited (ASX: $4DX) has secured participation in a pivotal burn pit research grant awarded by the U.S. Department of Veterans Affairs (VA). The study, in partnership with Vanderbilt University Medical Center (VUMC) and the Vanderbilt University Institute of Imaging Sciences (VUISS), will utilize 4DMedical's XV Technology® to advance the understanding of deployment related respiratory disease (DRRD) and improve non-invasive diagnosis of DRRD. The company's MD/CEO and Founder, Andreas Fouras, highlighted the significance of this study in solidifying 4DMedical's position as a leading technology for Veterans exposed to burn pits. The project, along with the recent news regarding the use of Imbio's LTA to detect pulmonary fibrosis in Veterans, underscores the growing profile and momentum 4D has at the VA.